• Comments on: Safety and efficacy of 3D-printed templates assisted CT-guided radioactive iodine-125 s...

• Shin Hyun-Soo

• Journal of Gynecologic Oncology   2021  Volume.32  No.2 50 ~ 50

• The 2020 Japan Society of Gynecologic Oncology guidelines for the treatment of ovarian cancer, fallo...

• Tokunaga Hideki

• Mikami Mikio, Nagase Satoru, Kobayashi Yoichi, Tabata Tsutomu, Kaneuchi Masanori, Satoh Toyomi,...

• Journal of Gynecologic Oncology   2021  Volume.32  No.2 49 ~ 49

• Post-LACC era: critical assessment not ¡°all-or-none¡± is needed

• Leitao Mario M. Jr.

• Kim Se-Ik, Kim Jae-Weon

• Journal of Gynecologic Oncology   2021  Volume.32  No.2 47 ~ 47

• Evaluating robotic surgical courses: structured training matters

• Falconer Henrik

• Journal of Gynecologic Oncology   2021  Volume.32  No.2 39 ~ 39

• Lumping and splitting: The need for precision medicine and ¡°personomics¡± in endometrial cancer

• Reyes-Baez Fiorella E.

• Garzon Simone, Mariani Andrea

• Journal of Gynecologic Oncology   2021  Volume.32  No.2 38 ~ 38

• How to start niraparib in real-world Asian ovarian cancer patients?

• Hong Sook-Hee

• Journal of Gynecologic Oncology   2021  Volume.32  No.2 36 ~ 36

• Increased risk of herpes zoster in gynecological cancer patients receiving radiotherapy combined wit...

• Shin Dong-Hoon

• Song Kyoung-Ho

• Journal of Gynecologic Oncology   2021  Volume.32  No.2 35 ~ 35

• Current status and future directions of ovarian cancer prognostic models

• Kobayashi Yusuke

• Banno Kouji, Aoki Daisuke

• Journal of Gynecologic Oncology   2021  Volume.32  No.2 34 ~ 34

• Comments on: Peripheral blood BRCA1 methylation profiling to predict familial ovarian cancer

• Kwon Janice S.

• Journal of Gynecologic Oncology   2021  Volume.32  No.2 33 ~ 33

• A single-arm phase II study of olaparib maintenance with pembrolizumab and bevacizumab in BRCA non-m...

• Lee Yong-Jae

• Lim Myong-Cheol, Kim Byoung-Gie, Ngoi Natalie Y. L., Choi Chel-Hun, Park Sang-Yoon, Tan David S...

• Journal of Gynecologic Oncology   2021  Volume.32  No.2 31 ~ 31

• Cost-effectiveness of olaparib versus routine surveillance in the maintenance setting for patients w...

• Tan David S. P.

• Chan Jack Junjie, Hettle Robert, Ghosh Wrik, Viswambaram Amrita, Yu Cindy Chen

• Journal of Gynecologic Oncology   2021  Volume.32  No.2 27 ~ 27

• Implementation and evaluation of a novel subspecialty society fellows robotic surgical course: the S...

• Boitano Teresa K. L.

• Smith Haller J., Cohen Joshua G., Rossi Emma C., Kim Kenneth H.

• Journal of Gynecologic Oncology   2021  Volume.32  No.2 26 ~ 26

• Lymphadenectomy issues in endometrial cancer

• Konno Yosuke

• Asano Hiroshi, Shikama Ayumi, Aoki Daisuke, Tanikawa Michihiro, Oki Akinori, Horie Koji, M...

• Journal of Gynecologic Oncology   2021  Volume.32  No.2 25 ~ 25

• Hospital volume-outcome relationship in vulvar cancer treatment: a Japanese Gynecologic Oncology Gro...

• Matsuo Koji

• Nishio Shin, Matsuzaki Shinya, Machida Hiroko, Mikami Mikio

• Journal of Gynecologic Oncology   2021  Volume.32  No.2 24 ~ 24

• Peripheral blood BRCA1 methylation profiling to predict familial ovarian cancer

• Jung Yu-Yeon

• Hur Soo-Young, Liu Jing Jing, Lee San-Ha, Kang Byung-Soo, Kim Myung-Shin, Choi Youn-Jin

• Journal of Gynecologic Oncology   2021  Volume.32  No.2 23 ~ 23

• Recurrence risk factors in stage IA grade 1 endometrial cancer

• Nwachukwu Chika

• Baskovic Mana, Von Eyben Rie, Fujimoto Dylann, Giaretta Stephanie, English Diana, Kidd Elizabet...

• Journal of Gynecologic Oncology   2021  Volume.32  No.2 22 ~ 22

• Phase 2 single-arm study on the safety of maintenance niraparib in Japanese patients with platinum-s...

• Takehara Kazuhiro

• Matsumoto Takashi, Hamanishi Junzo, Hasegawa Kosei, Matsuura Motoki, Miura Kiyonori, Nagao Shoj...

• Journal of Gynecologic Oncology   2021  Volume.32  No.2 21 ~ 21

• Ovarian cancer risk score predicts chemo-response and outcome in epithelial ovarian carcinoma patien...

• Lu Hsiao-Yun

• Tai Yi-Jou, Chen Yu-Li, Chiang Ying-Cheng, Hsu Heng-Cheng, Cheng Wen-Fang

• Journal of Gynecologic Oncology   2021  Volume.32  No.2 18 ~ 18

• Comparison between laparoscopic and abdominal radical hysterectomy for stage IB1 and tumor size <2 c...

• Li Pengfei

• Chen Lan, Ni Yan, Liu Jiaqi, Li Donglin, Guo Jianxin, Liu Zhihua, Jin Shuangling, Xu ...

• Journal of Gynecologic Oncology   2021  Volume.32  No.2 17 ~ 17

• Phase 2 single-arm study on the efficacy and safety of niraparib in Japanese patients with heavily p...

• Okamoto Aikou

• Kondo Eiji, Nakamura Toshiaki, Yanagida Satoshi, Hamanishi Junzo, Harano Kenichi, Hasegawa Kose...

• Journal of Gynecologic Oncology   2021  Volume.32  No.2 16 ~ 16